To read this content please select one of the options below:

How blockchain technology supports the business processes of clinical trials: a systematic review

Afrooz Moatari-Kazerouni (School of Business Adminstration, Widener University, Chester, Pennsylvania, USA)
Dinesh R. Pai (School of Business Administration, The Pennsylvania State University Harrisburg, Middletown, Pennsylvania, USA)
Alejandro E. Chicas (School of Business Adminstration, Widener University, Chester, Pennsylvania, USA)
Amin Keramati (School of Business Adminstration, Widener University, Chester, Pennsylvania, USA)

Business Process Management Journal

ISSN: 1463-7154

Article publication date: 20 November 2023

Issue publication date: 17 April 2024

134

Abstract

Purpose

The authors propose a blockchain platform for managing clinical trial data to enhance data validity, integrity, trust and transparency in the pharmaceutical research process. The authors also provide an extensive review of how blockchain technology supports the business processes of clinical trials.

Design/methodology/approach

A systematic literature review was conducted to identify the existing applications of blockchain in pharmaceutical process management. A conceptual design for a blockchain infrastructure to address clinical trial challenges is developed by outlining the entire clinical trial value chain and identifying the coordination and communication among its stakeholders. A stakeholder analysis is conducted to ensure that the clinical trial processes satisfy the requirements and preferences of each stakeholder.

Findings

The proposed blockchain platform offers a promising solution for enhancing integrity, trust and transparency in the clinical trial process. Additionally, blockchain can help streamline communication and collaboration between stakeholders by enabling multiple parties to access and share data in real time, lowering the possibility of delays or errors in data analysis and reporting.

Practical implications

The proposed blockchain platform can benefit patients by empowering them to have better-controlled access to their data and by allowing researchers to maintain adherence to reporting requirements. Additionally, the platform can benefit granting agencies, researchers and decision-makers by ensuring the integrity of clinical trial data and streamlining communication and collaboration between stakeholders.

Originality/value

This study builds on existing blockchain applications in pharmaceutical process management by developing a blockchain framework that can address clinical trial concerns from an integrated perspective.

Keywords

Citation

Moatari-Kazerouni, A., Pai, D.R., Chicas, A.E. and Keramati, A. (2024), "How blockchain technology supports the business processes of clinical trials: a systematic review", Business Process Management Journal, Vol. 30 No. 2, pp. 388-410. https://doi.org/10.1108/BPMJ-04-2023-0301

Publisher

:

Emerald Publishing Limited

Copyright © 2023, Emerald Publishing Limited

Related articles